ATE272633T1 - Aromatische amiden - Google Patents

Aromatische amiden

Info

Publication number
ATE272633T1
ATE272633T1 AT99964279T AT99964279T ATE272633T1 AT E272633 T1 ATE272633 T1 AT E272633T1 AT 99964279 T AT99964279 T AT 99964279T AT 99964279 T AT99964279 T AT 99964279T AT E272633 T1 ATE272633 T1 AT E272633T1
Authority
AT
Austria
Prior art keywords
aromatic amides
inhibitor
factor
compound
formula
Prior art date
Application number
AT99964279T
Other languages
English (en)
Inventor
Douglas Wade Beight
Trelia Joyce Craft
Carl Penman Denny
Jeffry Bernard Franciskovich
Theodore Junior Goodson
Steven Edward Hall
David Kent Herron
Sajan Pariyadan Joseph
Valentine Joseph Klimkowski
John Joseph Masters
David Mendel
Guy Milot
Marta Maria Pineiro-Nunez
Jason Scott Sawyer
Robert Theodore Shuman
Gerald Floyd Smith
Anne Louise Tebbe
Jennifer Marie Tinsley
Leonard Crayton Weir
Michael Robert Wiley
Ying Kwong Yee
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE272633T1 publication Critical patent/ATE272633T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AT99964279T 1998-12-23 1999-12-15 Aromatische amiden ATE272633T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11355698P 1998-12-23 1998-12-23
PCT/US1999/029946 WO2000039118A1 (en) 1998-12-23 1999-12-15 Aromatic amides

Publications (1)

Publication Number Publication Date
ATE272633T1 true ATE272633T1 (de) 2004-08-15

Family

ID=22350118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99964279T ATE272633T1 (de) 1998-12-23 1999-12-15 Aromatische amiden

Country Status (9)

Country Link
US (3) US6635657B1 (de)
EP (1) EP1140903B1 (de)
JP (1) JP2002533454A (de)
AT (1) ATE272633T1 (de)
AU (1) AU2055500A (de)
CA (1) CA2361149A1 (de)
DE (1) DE69919212T2 (de)
ES (1) ES2226485T3 (de)
WO (1) WO2000039118A1 (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002506462A (ja) 1997-06-26 2002-02-26 イーライ・リリー・アンド・カンパニー 抗血栓物質
IL133625A0 (en) 1997-06-26 2001-04-30 Lilly Co Eli Antithrombotic agents
CA2294240A1 (en) 1997-06-26 1999-01-07 Trelia Joyce Craft Antithrombotic agents
EP1014962A4 (de) 1997-06-26 2007-06-27 Lilly Co Eli Antitrombotische mitteln
EP1140881B1 (de) 1998-12-23 2006-05-17 Eli Lilly And Company Antithrombotische amide
US6689780B1 (en) 1998-12-23 2004-02-10 Eli Lilly And Company Heteroroaromatic amides as inhibitor of factor Xa
CA2361149A1 (en) * 1998-12-23 2000-07-06 Eli Lilly And Company Aromatic amides
ATE261941T1 (de) 1998-12-24 2004-04-15 Lilly Co Eli Heterocyclische amide als inhibitoren von faktor xa
WO2000055152A1 (en) * 1999-03-12 2000-09-21 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds as anti-inflammatory agents
CA2375920A1 (en) 1999-06-14 2000-12-21 Eli Lilly And Company Compounds
CZ2002961A3 (cs) * 1999-09-17 2002-08-14 Millennium Pharmaceuticals, Inc. Benzamidy a příbuzné sloučeniny pro inhibici faktoru Xa
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
WO2001064642A2 (en) 2000-02-29 2001-09-07 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor xa
AU776053B2 (en) 2000-03-31 2004-08-26 Astellas Pharma Inc. Diazepan derivatives or salts thereof
TWI288745B (en) 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
DE10023484A1 (de) 2000-05-09 2001-11-22 Schering Ag Anthranylamide und deren Verwendung als Arzneimittel
GB0030303D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030306D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030305D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030304D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
ATE374765T1 (de) 2000-07-27 2007-10-15 Lilly Co Eli Substituierte heterocyclische amide
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
DE60114640T2 (de) 2000-08-17 2006-07-20 Eli Lilly And Co., Indianapolis Antithrombosemittel
DE60144284D1 (de) 2000-11-01 2011-05-05 Millennium Pharm Inc Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
DE60118774T2 (de) * 2000-11-22 2007-03-15 Astellas Pharma Inc. Substituierte phenolderivate und deren salze als hemmstoffe von koagulations faktor x
AU2001297648A1 (en) 2000-11-28 2002-08-28 Eli Lilly And Company Substituted carboxamides as inhibitors of factor xa
DE10063008A1 (de) * 2000-12-16 2002-06-20 Merck Patent Gmbh Carbonsäureamidderivate
US7105682B2 (en) * 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
US6995162B2 (en) 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7102009B2 (en) 2001-01-12 2006-09-05 Amgen Inc. Substituted amine derivatives and methods of use
US6878714B2 (en) * 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
US20030134836A1 (en) * 2001-01-12 2003-07-17 Amgen Inc. Substituted arylamine derivatives and methods of use
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
EP1456175A1 (de) 2001-12-07 2004-09-15 Eli Lilly And Company Substituierte heterozyklische karboxamide mit antithrombotischer aktivität
US7105489B2 (en) * 2002-01-22 2006-09-12 Amylin Pharmaceuticals, Inc. Methods and compositions for treating polycystic ovary syndrome
CA2476583C (en) * 2002-03-13 2011-07-05 Kristof Van Emelen Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
WO2003080585A1 (en) * 2002-03-26 2003-10-02 Banyu Pharmaceutical Co., Ltd. Novel aminobenzamide derivative
IL163923A0 (en) * 2002-03-28 2005-12-18 Tanabe Seiyaku Co Benzofuran derivatives
US7307088B2 (en) 2002-07-09 2007-12-11 Amgen Inc. Substituted anthranilic amide derivatives and methods of use
US7615565B2 (en) 2002-07-31 2009-11-10 Bayer Schering Pharma Aktiengesellschaft VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
DE10302500A1 (de) 2003-01-23 2004-07-29 Merck Patent Gmbh Carbonsäureamidderivate
DE10308907A1 (de) 2003-02-28 2004-09-09 Merck Patent Gmbh Ethynylderivate
WO2004080950A1 (en) * 2003-03-14 2004-09-23 H. Lundbeck A/S Substituted aniline derivatives
PL377633A1 (pl) * 2003-04-03 2006-02-06 Merck Patent Gmbh Związki karbonylowe
EP1644334B1 (de) * 2003-05-30 2008-01-02 Eli Lilly and Company Antitrombotische aether
AR044688A1 (es) * 2003-06-12 2005-09-21 Euro Celtique Sa Agentes terapeuticos utiles para el tratamiento del dolor
TW200512181A (en) 2003-09-26 2005-04-01 Tanabe Seiyaku Co Amide-type carboxamide derivatives
TW200524915A (en) * 2003-09-26 2005-08-01 Tanabe Seiyaku Co Carbamoyl-type benzofuran derivatives
US7511066B2 (en) * 2003-09-30 2009-03-31 Eli Lilly And Company Antithrombotic aromatic ethers
US7906533B2 (en) 2004-11-03 2011-03-15 Bayer Schering Pharma Ag Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
EP1655295A1 (de) 2004-11-03 2006-05-10 Schering Aktiengesellschaft Anthranilamid-Pyridinharnstoffe als VEGF Rezeptor Kinase Inhibitoren
EP1657241A1 (de) 2004-11-03 2006-05-17 Schering Aktiengesellschaft Neue Antranilamidpyrdinharnstoffe mit hemmender Wirkung auf VEGF-Rezeptor Kinase
ATE457302T1 (de) 2004-11-24 2010-02-15 Lilly Co Eli Aromatische etherderivate als thrombin-hemmer
EP1819693B1 (de) * 2004-11-29 2009-08-26 Eli Lilly And Company Antithrombotische diamide
WO2006070878A1 (ja) * 2004-12-28 2006-07-06 Astellas Pharma Inc. カルボン酸誘導体またはその塩
US7264402B2 (en) * 2005-03-10 2007-09-04 Corning Cable Systems Llc Multi-fiber optic receptacle and plug assembly
JP2006298909A (ja) * 2005-03-25 2006-11-02 Tanabe Seiyaku Co Ltd 医薬組成物
KR20110084339A (ko) 2005-07-09 2011-07-21 아스트라제네카 아베 당뇨병 치료에 있어 glk 활성화제로서 사용하기 위한 헤테로아릴 벤즈아미드 유도체
US8247556B2 (en) * 2005-10-21 2012-08-21 Amgen Inc. Method for preparing 6-substituted-7-aza-indoles
EP2077995B1 (de) 2006-11-02 2012-02-08 Millennium Pharmaceuticals, Inc. Verfahren zur synthetisierung pharmazeutischer salze aus einem faktor-xa-hemmer
PT2101760E (pt) * 2006-12-08 2013-05-07 Millennium Pharm Inc Formulações de dose unitária e métodos de tratamento da trombose com um inibidor oral do fator xa
CL2008000986A1 (es) 2007-04-06 2008-10-17 Neurocrine Biosciences Inc COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV
MX2009010828A (es) 2007-04-06 2009-10-29 Neurocrine Biosciences Inc Antagonistas del receptor de la hormona liberadora de gonadotropina y metodos relacionados con los mismos.
CA2685121A1 (en) * 2007-04-27 2008-11-06 Purdue Pharma L.P. Therapeutic agents useful for treating pain
WO2012059442A2 (en) * 2010-11-01 2012-05-10 Neurotune Ag Neurotrypsin inhibitors
TWI554507B (zh) * 2011-08-26 2016-10-21 拜耳智慧財產有限公司 藉由苯并酮與胺反應製備經四唑取代之鄰胺苯甲酸二醯胺衍生物的方法
CN104245666B (zh) * 2012-02-07 2019-01-11 拜耳知识产权有限责任公司 取代的邻氨基苯甲酸衍生物的制备方法
CN103304489B (zh) * 2012-03-16 2015-03-11 中国农业科学院兰州畜牧与兽药研究所 嘧啶苯甲酰胺类化合物及其制备和应用
EP2924106A1 (de) * 2014-03-28 2015-09-30 The Procter and Gamble Company Dosierungsartikel für wasserlösliche Einheit
EP2924105A1 (de) * 2014-03-28 2015-09-30 The Procter and Gamble Company Dosierungsartikel für wasserlösliche Einheit
HK1243636A1 (zh) * 2014-11-18 2018-07-20 Rutgers, The State University Of New Jersey 用於治疗代谢疾病和癌症的新的线粒体解偶联剂
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
EP3458454B1 (de) 2016-05-18 2021-11-24 Rutgers, The State University of New Jersey 2-hydroxy-n-(benzo[d]thiazol-2-yl)benzamid-derivate als mitochondrien-entkoppler zur behandlung von stoffwechselerkrankungen und krebs
WO2020117877A1 (en) * 2018-12-04 2020-06-11 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use
CA3176265A1 (en) * 2020-03-30 2021-10-07 Boehringer Ingelheim International Gmbh Substituted 3-phenoxyazetidin-1-yl-pyrazines having gpr52 agonistic activity

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2295775A (en) * 1940-10-31 1942-09-15 Westinghouse Air Brake Co Compressor control apparatus
US4416683A (en) * 1980-09-16 1983-11-22 Eli Lilly And Company Benzamides, compositions and agricultural method
EP0813525B9 (de) * 1995-03-10 2004-02-04 Berlex Laboratories, Inc. Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
CA2294240A1 (en) 1997-06-26 1999-01-07 Trelia Joyce Craft Antithrombotic agents
IL133625A0 (en) 1997-06-26 2001-04-30 Lilly Co Eli Antithrombotic agents
EP1014962A4 (de) * 1997-06-26 2007-06-27 Lilly Co Eli Antitrombotische mitteln
JP2002506462A (ja) 1997-06-26 2002-02-26 イーライ・リリー・アンド・カンパニー 抗血栓物質
BE1011603A3 (nl) * 1997-12-11 1999-11-09 Picanol Nv Werkwijze en inrichting voor het controleren van een inslaginbreng bij een weefmachine.
US6140351A (en) 1997-12-19 2000-10-31 Berlex Laboratories, Inc. Ortho-anthranilamide derivatives as anti-coagulants
NZ503809A (en) 1997-12-19 2002-04-26 Schering Ag Ortho-anthranilamide derivatives as anti-coagulants
UA71587C2 (uk) * 1998-11-10 2004-12-15 Шерінг Акцієнгезелльшафт Аміди антранілової кислоти та їхнє застосування як лікарських засобів
ATE240316T1 (de) 1998-12-23 2003-05-15 Lilly Co Eli Heteroaromatische amide als inhibitoren von faktor xa
CA2361149A1 (en) * 1998-12-23 2000-07-06 Eli Lilly And Company Aromatic amides
EP1140881B1 (de) 1998-12-23 2006-05-17 Eli Lilly And Company Antithrombotische amide
ATE261941T1 (de) 1998-12-24 2004-04-15 Lilly Co Eli Heterocyclische amide als inhibitoren von faktor xa
US6675591B2 (en) * 2001-05-03 2004-01-13 Emerson Retail Services Inc. Method of managing a refrigeration system

Also Published As

Publication number Publication date
DE69919212T2 (de) 2005-07-28
DE69919212D1 (de) 2004-09-09
US20050282862A1 (en) 2005-12-22
JP2002533454A (ja) 2002-10-08
EP1140903B1 (de) 2004-08-04
US6635657B1 (en) 2003-10-21
WO2000039118A1 (en) 2000-07-06
CA2361149A1 (en) 2000-07-06
EP1140903A1 (de) 2001-10-10
ES2226485T3 (es) 2005-03-16
US7129245B2 (en) 2006-10-31
AU2055500A (en) 2000-07-31
US6759414B2 (en) 2004-07-06
US20040029874A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
DE69919212D1 (de) Aromatische amiden
ATE326453T1 (de) Antithrombotische amide
AU2001280438A1 (en) Substituted heterocyclic amides
ATE297203T1 (de) Antithrombotische mitteln
DE69831868D1 (en) Antithrombosemittel
AU2364600A (en) Heteroroaromatic amides as inhibitor of factor xa
AU2364000A (en) Heterocyclic amides as inhibitors of factor xa
NO20020214L (no) Substituerte oksoazaheterocyklylforbindelser
ATE440833T1 (de) Antithrombotische diamide
SE0102617D0 (sv) Novel compounds
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
DE602005019316D1 (en) Aromatische etherderivate als thrombin-hemmer
DE60114640D1 (en) Antithrombosemittel
ATE253359T1 (de) Antithrombotische mittel
ATE286395T1 (de) Antithrombotische mittel
DE602004011064D1 (en) Antitrombotische aether
ATE374751T1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern
IL166313A0 (en) Indoline derivatives and pharmaceutical compositions containing the same
DE60008430D1 (de) Verbindungen mit antithrombotischer wirkung
ATE268768T1 (de) Antithrombosemittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties